Page last updated: 2024-08-24

4-hydroxyaminopropiophenone and Methemoglobinemia

4-hydroxyaminopropiophenone has been researched along with Methemoglobinemia in 1 studies

*Methemoglobinemia: The presence of methemoglobin in the blood, resulting in cyanosis. A small amount of methemoglobin is present in the blood normally, but injury or toxic agents convert a larger proportion of hemoglobin into methemoglobin, which does not function reversibly as an oxygen carrier. Methemoglobinemia may be due to a defect in the enzyme NADH methemoglobin reductase (an autosomal recessive trait) or to an abnormality in hemoglobin M (an autosomal dominant trait). (Dorland, 27th ed) [MeSH]

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bright, JE; Marrs, TC1

Other Studies

1 other study(ies) available for 4-hydroxyaminopropiophenone and Methemoglobinemia

ArticleYear
Kinetics of methaemoglobin production. (1). Kinetics of methaemoglobinaemia induced by the cyanide antidotes, p-aminopropiophenone, p-hydroxyaminopropiophenone or p-dimethylaminophenol after intravenous administration.
    Human toxicology, 1986, Volume: 5, Issue:5

    Topics: Aminophenols; Animals; Antidotes; Computer Simulation; Cyanides; Dogs; Female; Injections, Intravenous; Kinetics; Methemoglobin; Methemoglobinemia; Models, Biological; Propiophenones

1986